The Federal Register

Importer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated July 31, 2007 and published in the Federal Register on August 9, 2007, (72 FR 44859), Almac Clinical Services Inc., (ACSI), 2661 Audubon Road, Audubon, Pennsylvania 19403, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Oxycodone (9143)........................... II

Fentanyl (9801)............................ II

The company plans to import small quantities of the listed controlled substances in dosage form to conduct clinical trials.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Almac Clinical Services Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or prot

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated July 10, 2007, and published in the Federal Register on July 24, 2007, (72 FR 40331), American Radiolabeled Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Gamma hydroxybutyric acid (2010)............ I
Ibogaine (7260)............................. I
Lysergic acid diethylamide (7315)........... I
Tetrahydrocannabinols (7370)................ I
Dimethyltryptamine (7435)................... I
1[1(2Thienyl)cyclohexyl]piperidine (7470) I
Dihydromorphine (9145)...................... I
Normorphine (9313).......................... I
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Amobarbital (2125).......................... II
Phencyclidine (7471)........................ II
Phe

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 5, 2007, (72 FR 36728), Amri Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Lisdexamfetamine (1205), a basic class of controlled substance listed in schedule II.

The company plans to manufacture the listed controlled substance in bulk for sales to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Amri Rensselaer, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Amri Rensselaer, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the compan

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated July 10, 2007, and published in the Federal Register on July 24, 2007, (72 FR 4033140332), Applied Science Labs, Division of Alltech Associates Inc., 2701 Carolean Industrial Drive, State College, Pennsylvania 16801, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Methcathinone (1237)........................ I
NEthylamphetamine (1475)................... I
N,NDimethylamphetamine (1480).............. I
4Methylaminorex (cis isomer) (1590)........ I
Alphaethyltryptamine (7249)................ I
Lysergic acid diethylamide (7315)........... I
2,5Dimethoxy4n)propylthiophenethylamine I
(2CT7) (7348).
Tetrahydrocannabinols (7370)................ I
Mescaline (7381)............................ I
4Bromo2,5dimethoxyamphetamine (7391)..... I
4Bromo2,5dimethoxyphenethylamine (7392)..

Importer of Controlled Substances; Notice of Application

Fri, Nov 16 2007 11:00:00 GMT

Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II and prior to issuing a registration under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing.

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on May 17, 2007, Aptuit, 10245 Hickman Mills Drive, Kansas City, Missouri 64137, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Marihuana (7360), a basic class of controlled substance listed in schedule I.

The company plans to import a finished pharmaceutical product containing cannabis extracts in dosage form for packaging for a clinical trial study.

Any bulk manufacturer who is presently, or is applying to be, regist

Manufacturer of Controlled Substances; Notice of Application

Fri, Nov 16 2007 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 13, 2007, Archimica, Inc., 2460 W. Bennett Street, Springfield, Missouri 658071229, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of
[[Page 64675]]
the basic classes of controlled substances listed in schedule II: Drug Schedule Methylphenidate (1724)..................... II
Phenylacetone (8501)....................... II

Methadone Intermediate (9254).............. II

The company plans to manufacture the listed controlled substances in bulk for research purposes, and sale to its customers.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections being sent via regu

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 5, 2007, (72 FR 36728), Austin Pharma LLC, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Alphamethadol (9605)....................... I
Methadone (9250)........................... II
Methadone Intermediate (9254).............. II
Levoalphacetylmethadol (9648)............. II
Alfentanil (9737).......................... II
Remifentanil (9739)........................ II
Sufentanil (9740).......................... II

Fentanyl (9801)............................ II

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.

Importer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated August 16, 2007 and published in the Federal Register on August 27, 2007, (72 FR 49018), Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance to bulk manufacture amphetamine.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Boehringer Ingelheim Chemicals, Inc. to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Boehringer Ingelheim Chemicals, Inc. to ensure that the company's registration is consistent

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 5, 2007, (72 FR 36728), Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Lisdexamfetamine (1205), a basic class of controlled substance listed in schedule II.

The company plans to qualify as a bulk manufacturer of the above listed controlled substance.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Boehringer Ingelheim Chemicals, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Boehringer Ingelheim Chemicals, Inc. to ensure that the company's registration is consistent with the public interest. The
[[Page 64676]]
investigation has included inspection and testing of the company'

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 3, 2007, (72 FR 36481), Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Codeine (9050), a basic class of controlled substance listed in schedule II.

The company plans to manufacture the listed controlled substance for sale as an intermediate to other opiates and supply as API to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cambrex Charles City, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Cambrex Charles City, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physic

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 7, 2007, and published in the Federal Register on June 20, 2007, (72 FR 3403934040), Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Hydromorphone (9150), a basic class of controlled substance listed in schedule II.

The company plans to manufacture the listed controlled substance for sale to its customers.

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 5, 2007, (72 FR 36729), Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Morphine (9300), a basic class of controlled substance listed in schedule II.

The company plans to manufacture the listed controlled substance for sale as an intermediate to generic drug customers.

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated July 31, 2007, and published in the Federal Register on August 9, 2007, (72 FR 44860), Cambrex North Brunswick, Inc., Technology Centre of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk [[Page 64677]]
manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule NEthylamphetamine (1475)................... I
Tetrahydrocannabinols (7370)................ I
2,5Dimethoxyamphetamine (7396)............. I
3,4Methylenedioxyamphetamine (7400)........ I
4Methoxyamphetamine (7411)................. I
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Methylphenidate (1724)...................... II
Pentobarbital (2270)........................ II
Phenylacetone (8501)........................ II
Hydromorphone (9150)........................ I

Manufacturer of Controlled Substances; Notice of Application

Fri, Nov 16 2007 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 6, 2007, Cambridge Isotope Lab, 50 Frontage Road, Andover, Massachusetts 01810, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Morphine (9300), a basic class of controlled substance listed in schedule II.

The company plans to utilize small quantities of the listed controlled substance in the preparation of analytical standards.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express

Manufacturer of Controlled Substances; Notice of Application

Fri, Nov 16 2007 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 16, 2007, Cody Laboratories, 601 Yellowstone Avenue, Cody, Wyoming 82414, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Codeine (9050)............................. II
Ecgonine (9180)............................ II
Hydrocodone (9193)......................... II

Morphine (9300)............................ II

The company plans on manufacturing the listed controlled substances in bulk for sale to its customers.

Any such written comments or objections being sent vi

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 3, 2007, (72 FR 36481), Dade Behring, Inc., 100 GBC Drive, MS514, Post Office Box 6101, Attention: RA/GS, Newark, Delaware 197146101, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: Drug Schedule Tetrahydrocannabinols (7370)............... I
Benzoylecgonine (9180)..................... II

Morphine (9300)............................ II

The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator/ controls for DEA exempt products.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Dade Behring, Inc. to manufacture the listed basic class of controlled substance is consiste

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 5, 2007, (72 FR 36729), Dade Behring Inc., Regulatory Affairs, Quality Systems, 20400 Mariani Avenue, Cupertino, California 95014, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: Drug Schedule Tetrahydrocannabinols (7370)............... I
Benzoylecgonine (9180)..................... II

Morphine (9300)............................ II

The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator/ controls for DEA exempt products.

Importer of Controlled Substances; Notice of Application

Fri, Nov 16 2007 11:00:00 GMT

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on June 22, 2007, Fisher Clinical Services Inc., 7554 Schantz Road, Allentown, Pennsylvania 18106, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Noroxymorphone (9668), a basic class of controlled substance listed in schedule II.

The company plans to import the listed substance for analytical research and clinical trials.

Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture su

Importer of Controlled Substances; Notice of Application

Fri, Nov 16 2007 11:00:00 GMT

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on August 23, 2007, Formulation Technologies LLC., 11400 Burnet Road, Suite 4010, Austin, Texas 78758, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Fentanyl (9801), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance for clinical trials, research, analytical purposes, and distribution to its customers.

Any bulk manufacturer who is presently, or is ap

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 5, 2007, (72 FR 3672736728), Aldrich Chemical Company, Inc., DBA Isotec, 3858 Benner Road, Miamisburg, Ohio 45342, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Cathinone (1235)............................ I
Methcathinone (1237)........................ I
NEthylamphetamine (1475)................... I
N,NDimethylamphetamine (1480).............. I
Aminorex (1585)............................. I
Gamma Hydroxybutyric Acid (2010)............ I
Methaqualone (2565)......................... I
Ibogaine (7260)............................. I
Lysergic acid diethylamide (7315)........... I
Tetrahydrocannabinols (7370)................ I
Mescaline (7381)............................ I
2,5Dimethoxyamphetamine (7396).............

Importer of Controlled Substances; Notice of Application

Fri, Nov 16 2007 11:00:00 GMT

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on October 5, 2007, JFC Technologies LLC., 100 West Main Street, P.O. Box 669, Bound Brook, New Jersey 08805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Meperidine intermediateB (9233), a basic class of controlled substance listed in schedule II.

The company plans to import the basic class of controlled substance for the production of controlled substances for clinical trials, research, analytical purposes, and distrib

Manufacturer of Controlled Substances; Notice of Application

Fri, Nov 16 2007 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 24, 2007, JFC Technologies, LLC., 100 W. Main Street, Bound Brook, New Jersey 08805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Diphenoxylate (9170)....................... II

Hydrocodone (9193)......................... II

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.

Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforceme

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 3, 2007, (72 FR 36482), Johnson Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 080661742, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II: Drug Schedule Cocaine (9041)............................. II

Ecgonine (9180)............................ II

The company plans on producing cocaine for sale to its customers, who are final dosage manufacturers. The ecgonine is formed during the manufacturing process for cocaine.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DE

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 5, 2007, (72 FR 36727), Abbott Laboratories, DBA Knoll Pharmaceutical Company, 30 North Jefferson Road, Whippany, New Jersey 07981, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: Drug Schedule Dihydromorphine (9145)..................... I

Hydromorphone (9150)....................... II

The company plans to manufacture bulk product and dosage units for distribution to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Abbott Laboratories to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Abbott Laboratories to ensure that the company's r

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 5, 2007, (72 FR 3672936730), Lin Zhi International Inc., 687 North Pastoria Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
[[Page 64682]]
Drug Schedule Tetrahydrocannabinols (7370)............... I
3,4Methylenedioxymethamphetamine (7405) I
Cocaine (9041)............................. II
Oxycodone (9143)........................... II
Hydrocodone (9193)......................... II
Methadone (9250)........................... II
Dextropropoxyphene, bulk, (9273)........... II

Morphine (9300)............................ II

The company plans to manufacture the listed controlled substances as bulk reagents for use in drug abuse testing.

No comments or objections have been received. DEA has

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 3, 2007, (72 FR 36483), Lonza Riverside, 900 River Road, Conshohocken, Pennsylvania 19428, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Gamma hydroxybutyric acid (2010)........... I
Amphetamine (1100)......................... II

Methylphenidate (1724)..................... II

The company plans to manufacture bulk products for finished dosage units and distribution to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Lonza Riverside to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Lonza Riverside to ensure that the com

Manufacturer of Controlled Substances; Notice of Application

Fri, Nov 16 2007 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 5, 2007, National Center for Natural Products ResearchNIDA MProject, University of Mississippi, 135 Coy Waller Lab Complex, University, Mississippi 38677, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I:
Drug Schedule Marihuana (7360)........................... I

Tetrahydrocannabinols (7370)............... I

The company plans to cultivate marihuana for the National Institute on Drug Abuse for research approved by the Department of Health and Human Services.

Any such written

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 5, 2007, (72 FR 36730), Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Tetrahydrocannabinols (7370)............... I
Methylphenidate (1724)..................... II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Noroxymorphone (9668)...................... II

Fentanyl (9801)............................ II

The company plans to manufacture the listed controlled s

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 5, 2007, (72 FR 36730), Siegfried (USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Dihydromorphine (9145)..................... I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Glutethimide (2550)........................ II
Codeine (9050)............................. II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Methadone (9250)........................... II
Methadone i

Manufacturer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated June 26, 2007, and published in the Federal Register on July 5, 2007, (72 FR 3673036731), Sigma Aldrich Research Biochemicals, Inc., 13 Strathmore Road, Natick, Massachusetts 01760, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Cathinone (1235)............................ I
Methcathinone (1237)........................ I
Aminorex (1585)............................. I
Alphaethyltryptamine (7249)................ I
Lysergic acid diethylamide (7315)........... I
Tetrahydrocannabinols (7370)................ I
4Bromo2,5dimethoxyamphetamine (7391)..... I
4Bromo2,5dimethoxyphenethylamine (7392).. I
2,5Dimethoxyamphetamine (7396)............. I
3,4Methylenedioxyamphetamine (7400)........ I
NHydroxy3,4methylenedioxyamphetamine I
(7402).
3,4MethylenedioxyNethylamphetamine (740

Importer of Controlled Substances; Notice of Registration

Fri, Nov 16 2007 11:00:00 GMT

By Notice dated April 17, 2007 and published in the Federal Register on April 30, 2007, (72 FR 2129821299), Stepan Company, Natural Products Department, 100 W. Hunter Avenue, Maywood, New Jersey 07607, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Coca Leaves (9040), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance for the manufacture of a bulk controlled substance for distribution to its customer.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Stepan Company to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Stepan Company to ensure that the company's registration i

Importer of Controlled Substances; Notice of Application

Fri, Nov 16 2007 11:00:00 GMT

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on August 9, 2007, Tocris Cookson, Inc., 16144 Westwoods Business Park, Ellisville, Missouri 63021, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule I:
Drug Schedule Marihuana (7360)........................... I

Tetrahydrocannabinols (7370)............... I

The company plans to import the above listed synthetic prod